Addenda Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Sell
39,047
-407
-1% -$195K 0.53% 45
2026
Q1
$19.4M Buy
39,454
+9,971
+34% +$5.41M 0.55% 42
2025
Q4
$17.1M Sell
29,483
-274
-0.9% -$155K 0.5% 46
2025
Q3
$14.4M Buy
29,757
+8,689
+41% +$4.04M 0.43% 57
2025
Q2
$8.55M Buy
21,068
+1,880
+10% +$786K 0.31% 74
2025
Q1
$9.55M Sell
19,188
-127
-0.7% -$68.8K 0.35% 62
2024
Q4
$10.1M Buy
19,315
+1,279
+7% +$703K 0.35% 62
2024
Q3
$11.2M Sell
18,036
-13
-0.1% -$7.7K 0.4% 52
2024
Q2
$9.99M Sell
18,049
-1,314
-7% -$753K 0.39% 63
2024
Q1
$11.3M Sell
19,363
-4,101
-17% -$2.3M 0.43% 49
2023
Q4
$12.5M Sell
23,464
-185
-0.8% -$89.5K 0.49% 42
2023
Q3
$12M Sell
23,649
-293
-1% -$156K 0.52% 40
2023
Q2
$12.5M Sell
23,942
-5,522
-19% -$2.98M 0.52% 38
2023
Q1
$17M Sell
29,464
-437
-1% -$246K 0.7% 35
2022
Q4
$16.5M Sell
29,901
-2,160
-7% -$1.14M 0.72% 33
2022
Q3
$16.3M Sell
32,061
-6,037
-16% -$3.38M 0.74% 28
2022
Q2
$20.7M Sell
38,098
-5,776
-13% -$3.18M 0.99% 26
2022
Q1
$25.9M Buy
43,874
+2,846
+7% +$1.63M 1.06% 26
2021
Q4
$27.4M Sell
41,028
-2,081
-5% -$1.3M 1.18% 26
2021
Q3
$24.6M Sell
43,109
-4,085
-9% -$2.24M 1.16% 27
2021
Q2
$23.8M Sell
47,194
-263
-0.6% -$124K 1.12% 26
2021
Q1
$22.1M Hold
47,457
1.13% 29
2020
Q4
$22.1M Sell
47,457
-4,322
-8% -$2.03M 1.39% 24
2020
Q3
$22.9M Sell
51,779
-3,118
-6% -$1.29M 1.67% 22
2020
Q2
$19.9M Sell
54,897
-2,703
-5% -$906K 1.39% 25
2020
Q1
$16.3M Buy
57,600
+7,226
+14% +$2.28M 1.39% 22
2019
Q4
$16.4M Buy
50,374
+2,907
+6% +$881K 1.08% 26
2019
Q3
$13.8M Sell
47,467
-1,331
-3% -$381K 0.97% 27
2019
Q2
$14.3M Sell
48,798
-8,364
-15% -$2.3M 1.04% 26
2019
Q1
$15.7M Buy
57,162
+3,083
+6% +$767K 1.13% 24
2018
Q4
$11.9M Buy
54,079
+379
+0.7% +$88.9K 1.05% 24
2018
Q3
$12.9M Sell
53,700
-11,933
-18% -$2.75M 1.07% 24
2018
Q2
$13.4M Sell
65,633
-4,174
-6% -$886K 1.09% 25
2018
Q1
$14.2M Sell
69,807
-2,698
-4% -$566K 1.07% 21
2017
Q4
$13.6M Sell
72,505
-4,795
-6% -$919K 0.94% 24
2017
Q3
$14.4M Sell
77,300
-7,022
-8% -$1.27M 1.01% 20
2017
Q2
$14.5M Sell
84,322
-2,739
-3% -$460K 1.08% 21
2017
Q1
$13.2M Sell
87,061
-9,162
-10% -$1.4M 1.02% 23
2016
Q4
$13.3M Sell
96,223
-1,582
-2% -$233K 1.06% 20
2016
Q3
$14.1M Hold
97,805
1.17% 22
2016
Q2
$14.1M Sell
97,805
-31
-0% -$4.58K 1.17% 22
2016
Q1
$13.5M Buy
97,836
+645
+0.7% +$86.4K 1.18% 21
2015
Q4
$13.4M Sell
97,191
-11,052
-10% -$1.47M 1.26% 20
2015
Q3
$12.3M Sell
108,243
-1,558
-1% -$203K 1.17% 22
2015
Q2
$13.2M Sell
109,801
-234
-0.2% -$30.5K 1.13% 24
2015
Q1
$13.7M Sell
110,035
-1,427
-1% -$184K 1.16% 24
2014
Q4
$13.1M Buy
111,462
+16,393
+17% +$1.99M 1.04% 24
2014
Q3
$11.5M Buy
95,069
+3,650
+4% +$444K 1.02% 25
2014
Q2
$10.8M Buy
91,419
+1,782
+2% +$210K 0.91% 29
2014
Q1
$10.8M Buy
89,637
+24
+0% +$2.85K 0.97% 27
2013
Q4
$9.97M Buy
89,613
+1,791
+2% +$178K 0.89% 29
2013
Q3
$8.11M Buy
87,822
+4,830
+6% +$437K 0.74% 34
2013
Q2
$6.97M Buy
+82,992
New +$6.91M 0.68% 33

Other funds holding TMO

Addenda Capital's TMO Position: Q2 2026 in Review

Addenda Capital reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, selling an estimated $195K and leaving 39,047 shares worth $19.6M. The position accounts for 0.53% of the portfolio, ranked #45.

Addenda Capital first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.4M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Addenda Capital held 39,047 shares of Thermo Fisher Scientific worth $19.6M as of Q2 2026.
  • Addenda Capital sold 407 Thermo Fisher Scientific shares in Q2 2026, an estimated $195K.
  • Thermo Fisher Scientific made up 0.53% of Addenda Capital's portfolio in Q2 2026, its #45 holding.
  • Addenda Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Addenda Capital's Thermo Fisher Scientific position peaked at $27.4M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Addenda Capital's 13F filing for Q2 2026, filed 14 Jul 2026.